India US Trade Deal: What Is the Price of a Handshake?

A handshake can settle a disagreement between leaders. It cannot tell a dairy farmer what next season’s milk price will be, or a patient whether an affordable generic medicine will remain available.

That distinction should guide the debate over the India US trade deal. In September, US Ambassador Sergio Gor suggested that an agreement was close and a Modi Trump meeting could happen around the December G20 summit. Neither optimism nor a possible bilateral meeting amounts to a completed agreement.

The question is not whether better relations with Washington are desirable. It is whether India receives durable commercial benefits without accepting disproportionate costs for agriculture, affordable medicines, digital governance and energy security.

The real test is not what the leaders announce. It is what the agreement requires India to change.

What Is Actually on the Negotiating Table?

The latest negotiations began during Prime Minister Modi’s February 2025 visit to Washington. In February 2026, the countries announced a framework for an interim agreement, while continuing work towards a broader bilateral trade agreement.

These are different stages. A framework records the direction of negotiations. A completed agreement must establish precise commitments, exceptions, implementation dates and mechanisms for resolving disputes.

The February framework envisaged Indian tariff reductions on industrial goods and selected agricultural products, including tree nuts, soybean oil, fruit and certain animal feeds. It also proposed further negotiations on digital trade.

It did not establish that India had accepted every American demand on dairy, patents or data localisation. Criticism should therefore examine published commitments and unresolved risks, not present a negotiating wishlist as an accomplished surrender.

What a Modi Trump Handshake Could Deliver

A leaders’ meeting could provide political clearance for difficult compromises, establish implementation deadlines and reduce uncertainty for exporters.

More predictable duties, simpler customs procedures and clearer product standards could make it easier for Indian businesses to price orders and plan investment. Equally, carefully chosen reductions in Indian import duties could lower input costs for domestic manufacturers.

But a handshake cannot automatically remove tariffs imposed under separate legal authorities, prevent future investigations or make an uncompetitive industry competitive overnight.

India should judge the bargain against the barriers businesses actually face. A dramatic headline reduction is less useful when another duty, restrictive quota or costly certification requirement continues to block access.

Why the 12.5 Percent Tariff Claim Needs Updating

India should not be described as sitting in a single, settled 12.5 percent US tariff bracket.

That figure appeared in the June 2026 proposal connected to forced labour import restrictions. The final USTR action announced on July 23 placed India in the 10 percent Section 301 category, subject to product exemptions. This addressed alleged shortcomings in prohibiting imports made with forced labour, not a finding that every Indian export involved forced labour.

For covered Indian goods, the additional duty sits alongside ordinary customs duties. Product classification and exemptions therefore matter more than a headline percentage.

PrepAiro’s earlier explanation of the US tariff shock and textile exports provides background to the June proposal. The later notification is essential when discussing the applicable measure.

Agriculture Cannot Be Reduced to Cheaper Imports

American pressure for agricultural access is documented. The USTR’s 2025 trade barriers report challenged restrictions affecting dairy and agricultural biotechnology, including certification requirements. That establishes a negotiating interest, not an Indian concession.

The government’s position also deserves accurate treatment. In February, Commerce Minister Piyush Goyal said dairy, poultry, rice and wheat were outside the arrangement. Farmer organisations nevertheless protested over potential livelihood losses.

The critical question is whether those protections survive in binding schedules and exceptions. Excluding a sensitive product today is less reassuring when broad review clauses leave tomorrow’s treatment uncertain.

The economic effects also need separating. Cheaper feed could benefit poultry producers. Cheaper imports competing directly with domestic output could depress prices received by farmers. Consumers, processors, cultivators and agricultural workers do not necessarily gain together.

The slogan “600 million farmers” should not substitute for evidence. Cultivators, agricultural labourers and people supported by agricultural households are different categories. Livelihood protection does not require inflating the number of farmers.

Food sovereignty should mean preserving the ability to maintain food security, viable livelihoods and accountable standards. It need not mean rejecting every agricultural import.

India should demand transparent product schedules, phased concessions where necessary, credible safeguards against damaging import surges and consultation with affected producers.

GMO Access Requires a Separate Regulatory Test

Tariff access, approval to import a genetically modified product and permission to cultivate a genetically modified crop are not interchangeable decisions.

The biotechnology disputes described in the USTR report concern approval processes and food or feed trade. They should not be converted into an unsupported claim that India has agreed to unrestricted cultivation of American GMO crops.

The appropriate safeguard is independent, transparent and science based assessment. India should retain the ability to examine biosafety, enforce applicable labelling requirements and distinguish between food, feed, seed and processed products.

Neither an automatic rejection of biotechnology nor approval driven by a diplomatic deadline provides a sound regulatory model.

The Pharmaceutical Risk Runs in the Opposite Direction

The claim that Washington wants lower pharmaceutical patent protection reverses the dispute.

The USTR’s 2026 Special 301 Report criticises aspects of India’s patent system, including restrictions under Section 3(d), patent opposition procedures and protection of pharmaceutical test data. The pressure is towards stronger intellectual property protection.

For India, the concern is whether additional exclusivity obligations could delay generic competition or narrow public health safeguards. These are risks to evaluate in the negotiated text, not changes already proved to have been accepted.

The WTO’s Doha Declaration on TRIPS and Public Health recognises members’ ability to use TRIPS flexibilities to protect public health, including compulsory licensing.

India can improve patent examination, reduce administrative delays and reward genuine innovation without treating every additional demand for exclusivity as necessary reform. Faster administration and weaker safeguards are not the same thing.

Digital Trade Should Preserve the Right to Regulate

Digital trade rules could benefit Indian service exporters and smaller businesses as well as American technology companies. The relevant question is which restrictions serve a legitimate purpose and which merely add cost.

India’s existing localisation requirements are not one blanket prohibition covering all information. For example, RBI’s payment data directions concern payment system data and contain specific treatment for the foreign portion of transactions.

A future trade agreement should preserve proportionate powers for privacy protection, financial supervision, cybersecurity and regulatory access. It should also provide transparent procedures so businesses know what compliance requires.

The February framework commits the countries to negotiate digital rules. It does not, by itself, prove that India has agreed to dismantle its localisation framework.

The danger would be accepting broadly worded restrictions on future regulation in exchange for tariff relief that proves temporary.

The UK Agreement Contains a Less Obvious Warning

The India UK agreement’s digital trade chapter offers a useful comparison. It addresses electronic contracts, paperless trade and consumer protection, showing that digital cooperation need not begin with abandoning domestic safeguards.

Its Article 12.20 deserves particular attention. When a party subsequently enters a qualifying agreement with another country containing specified data protection, transfer or localisation disciplines, the other party can request consultations on extending appropriate equivalent disciplines.

This is not automatic extension of every concession. The provision also protects personal data safeguards under domestic law.

The possible implication is nevertheless important: certain commitments to Washington could prompt London to seek comparable treatment. Negotiators should assess the cumulative effect across agreements, not price each concession as though it existed in isolation.

Russian Oil Makes Tariff Relief Less Secure

The Lindsey O. Graham Sanctioning Russia Act of 2026 initiative links trade pressure with purchases of Russian energy.

As of Reuters’ September 17 report, the sanctions bill had passed the House and been sent to President Trump for signature. It would authorise tariffs of up to 100 percent against countries buying Russian energy. That legislative position should not be confused with an already implemented 100 percent tariff on Indian goods.

The governance problem is clear. A commercial agreement may offer market access while a separate geopolitical instrument threatens to withdraw its value.

India should evaluate energy diversification through supply reliability, total costs and strategic risk. It should also seek clarity on exemptions and implementation before treating ordinary tariff concessions as protection against future sanctions pressure.

What Would Make This a Good Deal for India?

A defensible agreement needs measurable reciprocal benefits, published exceptions and enforceable procedures. Sensitive sectors should not depend on verbal assurances, while exporters need clarity about competing tariff instruments.

India should publish assessments by sector, explain adjustment support for vulnerable producers and retain lawful public health and regulatory powers. Where commitments are phased, the corresponding benefits should arrive on a credible timetable.

For UPSC, this connects GS II themes of diplomacy and institutional accountability with GS III questions about agriculture, external trade and inclusive growth. PrepAiro’s economy preparation guide can help place these connections within broader revision.

The strongest conclusion is neither that every concession is surrender nor that every agreement is progress. National gains must be judged alongside their distribution and durability.

A handshake can open markets. Only the fine print can show whether India has paid a fair price.